# Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/risk-of-tuberculosis-in-patients-with-inflammatory-bowel-disease-on-infliximab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Saurabh Kedia,Venigalla Pratap Mouli,Nagesh Kamat,Jeeva Sankar,Ashwin N. Ananthakrishnan,Govind Makharia,Vineet Ahuja |
| Citations | 68 |
| DOI | 10.14309/ajg.0000000000000527 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3004872336 |
| PMID | 32032073 |
| Type | review |
| Year | 2020 |

## Paper authors

- [Nagesh Kamat](https://scholariq.org/researchers/nagesh-kamat/)

## Paper journal

- [The American Journal of Gastroenterology](https://scholariq.org/journals/the-american-journal-of-gastroenterology/)

## Paper primary topic

- [Diagnosis and treatment of tuberculosis](https://scholariq.org/topics/diagnosis-and-treatment-of-tuberculosis/)

## Paper topics

- [Diagnosis and treatment of tuberculosis](https://scholariq.org/topics/diagnosis-and-treatment-of-tuberculosis/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.